EGFR and neoplasm: Addition of fluorescein-conjugated anti-EGFR monoclonal antibody resulted in cell lysis of EGFR-expressing tumor cells while addition of fluorescein-conjugated anti-CD38 monoclonal antibody resulted in cell lysis of CD38-expressing tumor cells.